An increase in awareness about Attention Deficit Hyperactivity Disorder or ADHD has led to more people being diagnosed with the disorder and wider recognition of challenges faced by neurodivergent workers. But the uptick has had an unintended side effect — a nationwide shortage of stimulants used to treat ADHD such as Adderall, Concerta, and Vyvanse.